ArticleTargeted oncology2021

Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab.

Yoshiyasu Kono et al.PubMed ↗Publisher ↗

No numbers read from the abstract.